Pre-clinical studies suggest that low B12 may contribute to fat accumulation and disrupt lipid metabolism (how the body processes and uses fats for energy and storage)[1]
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
Sofwave has been cleared by the FDA and has since become one of our preferred skin tightening treatments
Set the vial down
How soon will I feel the benefits
NextechLabs' products are intended solely for laboratory research purposes and are not to be used for any other purposes, including but not limited to vitro diagnostic purpose, in food drugs, medical devices, or cosmetics for humans or animals or for commercial purposes
